Hydrocortisone valerate and Fainting - a phase IV clinical study of FDA data

Summary:

Fainting is reported as a side effect among people who take Hydrocortisone valerate (hydrocortisone valerate), especially for people who are female, 50-59 old, also take Atenolol, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Fainting when taking Hydrocortisone valerate. It is created by eHealthMe based on reports of 606 people who have side effects when taking Hydrocortisone valerate from the FDA, and is updated regularly.

What is Hydrocortisone valerate?

Hydrocortisone valerate has active ingredients of hydrocortisone valerate. eHealthMe is studying from 609 Hydrocortisone valerate users. Check the latest studies of Hydrocortisone valerate.

What is Fainting?

Fainting (loss of consciousness and postural tone) is found to be associated with 2,459 drugs and 3,547 conditions by eHealthMe. Check the latest studies of Fainting.

On Jul, 16, 2026

606 people reported to have side effects when taking Hydrocortisone valerate.
Among them, 22 people (3.63%) have Fainting.

Could Hydrocortisone valerate cause Fainting?

Among these 22 people:

What is the gender of people who have Fainting when taking Hydrocortisone valerate? *

female: 93.75 %
male: 6.25 %

What is the age of people who have Fainting when taking Hydrocortisone valerate? *

What are other drugs people take besides Hydrocortisone valerate? *

Atenolol: 20 people, 90.91%
Medrol: 19 people, 86.36%
Zopiclone: 18 people, 81.82%
Prevacid: 18 people, 81.82%
Aripiprazole: 18 people, 81.82%
Cetirizine Hydrochloride: 18 people, 81.82%
Claritin: 18 people, 81.82%
Clonazepam: 18 people, 81.82%
Cymbalta: 18 people, 81.82%
Dilaudid: 18 people, 81.82%

What are other side effects people have besides Fainting? *

Dizziness: 21 people, 95.45%
Back Pain: 20 people, 90.91%
Diarrhea: 20 people, 90.91%
Pain: 20 people, 90.91%
Depression: 20 people, 90.91%
Fatigue (feeling of tiredness): 19 people, 86.36%
Drug Ineffective: 19 people, 86.36%
Weight Decreased: 19 people, 86.36%
Weakness: 19 people, 86.36%
Dyspnea (difficult or laboured breathing): 19 people, 86.36%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 13 people, 59.09%
Hypersensitivity: 11 people, 50.00%
Sleep Disorder: 8 people, 36.36%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 4.55%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 4.55%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Hydrocortisone valerate and have Fainting?

- Check whether Fainting is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hydrocortisone valerate:

Hydrocortisone valerate (609 reports)

Fainting treatments and more:

Fainting (131,321 reports)

Browse all side effects of Hydrocortisone valerate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fainting:

Fainting (2,459 drugs)

Browse all the conditions that are associated with Fainting:

Fainting (3,547 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on hydrocortisone valerate (the active ingredients of Hydrocortisone valerate) and Hydrocortisone valerate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.